COMMUNIQUÉS West-GlobeNewswire

-
EDAP to Present at the Jefferies Global Healthcare Conference
27/05/2025 -
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease
27/05/2025 -
Algernon Announces $1M Private Placement
27/05/2025 -
NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists
27/05/2025 -
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration
27/05/2025 -
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference
27/05/2025 -
GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
27/05/2025 -
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
27/05/2025 -
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.
27/05/2025 -
See All AI Raises $33 Million to Bring Revolutionary AI-Based Sliceable Intraoperative 3D Visualization and Advanced Navigation to Global Healthcare
27/05/2025 -
BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
27/05/2025 -
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
27/05/2025 -
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
27/05/2025 -
BioCryst to Present at Upcoming Investor Conferences
27/05/2025 -
Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
27/05/2025 -
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
27/05/2025 -
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
27/05/2025 -
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
27/05/2025 -
Adagene to Present at Jefferies Global Healthcare Conference 2025
27/05/2025
Pages